Medication info
Lipitan Tablets 20 mg (Atorvastatin Calcium Hydrate)

Lipitan Tablets 20 mg (Atorvastatin Calcium Hydrate)

Prescription medicationTablet
Ingredient · strength
Atorvastatin Calcium Hydrate›21.7mg / 1 tablet
Manufacturer / importer
McNulty Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201803145 · Approved 2018.07.30 · Insurance code 641502840

Summary

Main use
Improvement of hyperlipidemia (including familial hyperlipidemia in children); prevention of cardiovascular diseases (such as myocardial infarction)
Who uses it
Adults · Children
Adult dosage
Patients receiving atorvastatin before and during treatment should follow a standard cholesterol-lowering diet. The medication may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (40 mg is intended only for patients requiring an LDL cholesterol reduction of 45 % or more). This medication is administered at a dose of 10 ∼ 80 mg once daily. The initial and maintenance doses of this medication should be individualized according to the patient's characteristics, taking into consideration the treatment goal and response. Lipid levels should be analyzed within 2 ∼ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and assessing the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medication is administered at a dose of 10 ∼ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not possible. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older patients: Efficacy and safety in older patients aged 70 years or older are generally similar to those in the general adult patient population.
Children's dosage
Pediatric patients with heterozygous familial hypercholesterolemia (10 ∼ 17 years): The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on administering doses of this drug higher than 20 mg in pediatric patients).

Ingredients

Manufacturer
McNulty Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia (including familial hyperlipidemia in children); prevention of cardiovascular diseases (such as myocardial infarction)

  • Coronary artery heart disease
  • myocardial infarction
  • stroke
  • vascular revascularization
  • chronic stable angina
  • retinopathy
  • albuminuria
  • hypertension
  • congestive heart failure
  • angina
  • hyperlipidemia
  • hypercholesterolemia
View approved original text

This medication helps reduce the risk of cardiovascular diseases. Specifically, it decreases the risk of myocardial infarction and stroke in adults with multiple risk factors such as hypertension, smoking, and family history, as well as in patients with type 2 diabetes. It also reduces the likelihood of hospitalization due to vascular revascularization, angina, and congestive heart failure. For patients with hyperlipidemia, it lowers total cholesterol and LDL cholesterol while raising HDL cholesterol, making it a useful adjunct to dietary therapy. It is particularly effective in pediatric patients with heterozygous familial hypercholesterolemia, helping to improve blood lipid levels. This medication is used to improve cardiovascular health and reduce the risk of disease.

Dosage and Administration

Adult dosage

Patients receiving atorvastatin before and during treatment should follow a standard cholesterol-lowering diet. The medication may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (40 mg is intended only for patients requiring an LDL cholesterol reduction of 45 % or more). This medication is administered at a dose of 10 ∼ 80 mg once daily. The initial and maintenance doses of this medication should be individualized according to the patient's characteristics, taking into consideration the treatment goal and response. Lipid levels should be analyzed within 2 ∼ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and assessing the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medication is administered at a dose of 10 ∼ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not possible. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older patients: Efficacy and safety in older patients aged 70 years or older are generally similar to those in the general adult patient population.

Children's dosage

Pediatric patients with heterozygous familial hypercholesterolemia (10 ∼ 17 years): The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on administering doses of this drug higher than 20 mg in pediatric patients).

Precautions

This medication may cause muscle-related side effects, so if severe muscle pain or weakness occurs or there is a significant rise in creatine kinase levels, discontinue use immediately and consult a doctor. Do not take this medication if there is active liver disease or if liver function test values are very high. Patients with muscle diseases, pregnant women, children under 10 years old, or those taking certain medications should not use this medication. Patients with a history of alcohol abuse or liver disease, impaired renal function, hypothyroidism, and the elderly should exercise extra caution when using this medication. During treatment, liver function and muscle status should be regularly monitored, and if any unusual symptoms arise, medical personnel should be notified immediately. This medication may interact with various drugs, so if you are taking other medications, inform your doctor or pharmacist, particularly when using certain antibiotics, antifungals, antiviral agents, some antihypertensives, and fibrate class drugs. Pregnant or breastfeeding women should not take this medication, and women of childbearing age should use appropriate contraception while taking it. The elderly and patients with impaired renal function are at higher risk of myopathy and should be monitored closely during treatment. There is no specific antidote for overdose, so visit a medical institution immediately for treatment according to symptoms. Keep this medication out of reach of children and store it safely in its original container.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 171 more
  • loss of appetite
  • constipation
  • abdominal bloating
  • indigestion
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngitis
  • laryngitis
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • impaired taste
  • memory loss
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorder
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • hepatic failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • blistering dermatitis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function test
  • elevated serum CK
  • positive urinary leukocytes
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function tests
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcers
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcer
  • dysphagia
  • melena
  • gingival bleeding
  • eclampsia
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • sensory abnormalities
  • dizziness
  • phototoxic reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • reduced libido
  • emotional lability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperkinesia
  • depression
  • tension
  • myositis
  • muscle disease
  • arthritis
  • bursitis
  • tenosynovitis
  • myasthenia gravis
  • contracture
  • elevated serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcers
  • erectile dysfunction
  • urinary tract infection
  • frequency
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • fibrocystic breast disease
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical secretion
  • nephritis
  • incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • discolored urine
  • hypoglycemia
  • increased appetite
  • vascular neurogenic edema
  • chest pain
  • angina
  • facial swelling
  • fever
  • neck stiffness
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive errors
  • ocular hemorrhage
  • hearing loss
  • glaucoma
  • corneal haze
  • loss of taste
  • dysgeusia
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • elevated potassium
  • increased BUN
  • cerebral infarction
  • palpitations
  • tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain the storage temperature between 1 and 30 degrees Celsius at room temperature to preserve the drug's efficacy for a longer period.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.